This is where we are going. The inspirational TED talk by Professor Steve Wilton backgrounds the journey using antisense oligonucleotides to treat genetic diseases. There are clear signposts we are heading in the right direction:
- successful animal models - announcement 12 March 2019
- appointment to SAB of Dr Rakesh Veedu from Centre of Comparative Genomics - announcement 22 March 2019
- evaluation of second generation CPPs and optimised variants in Q2 2019 - announcement 12 March 2019
Phylogica is supplying the vehicle with a sophisticated GPS to find the right address. Its the passenger on board who has the expertise to get the job done. What happens next could change the approach to precision medicine for any number of the 6000 rare genetic diseases.
Ann: Scientific Advisory Board Appointment, page-15
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $676.5M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 17.5¢ | $508.8K | 2.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 118941 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 183634 | 2 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable
